Follow us on

 
 
 
Italian Medicines Agency Agenzia Italiana del Farmaco

AIFA publishes the COVID-19 vaccines FAQS on Pharmacovigilance - AIFA publishes the COVID-19 vaccines FAQS on Pharmacovigilance

Asset Publisher

AIFA publishes the COVID-19 vaccines FAQS on Pharmacovigilance

The Italian Medicines Agency has published on its institutional portal a series of frequently asked questions (FAQs) on pharmacovigilance to clarify doubts and uncertainties relating to the issue.

Reports on the results of pharmacovigilance activities will also be published on a monthly basis. The monthly frequency was chosen in order to gather sufficient data to ensure robustness of analyses, comparisons and evaluation.

Such Reports will be primarily aimed at showing the results of the association analyses of the events reported with vaccination and, where possible, will contain reference values and expected values to facilitate judgment on safety of the various vaccines.

The FAQs are available at the link: https://www.aifa.gov.it/domande-e-risposte-farmacovigilanza-vaccini-covid-19

The Reports will be published on the page: https://www.aifa.gov.it/farmacovigilanza-vaccini-covid-19


Published on: 13 January 2021

Asset Publisher

Related documents

Asset Publisher

Galleria

Nested Applications

Last tweets

Go to Twitter profile

Multimedia

Campagna sull'uso consapevole degli antibiotici

Go to YouTube channel

go to beginning of content